Copyright © 2003 by the European Society of Cardiology.
Editorial
Why do we need prospective registries in patients with acute myocardial infarction?
Herzzentrum Ludwigshafen, Medizinische Klinik B, Ludwigshafen, Germany
* Corresponding author. Priv. Doz. Dr. Uwe Zeymer, FESC, Herzzentrum Ludwigshafen, Medizinische Klinik B, Bremserstrasse 79, D-67063 Ludwigshafen, Germany. Tel.: +49-621-503-4045; fax: +49-621-503-4002
E-mail address: Uwe.Zeymer@t-online.de
Received 10 July 2003; accepted 10 July 2003
| The first 10% of the full text of this article appears below. |
See doi:10.1016/S1095-668X(03)00278-1for the article to which this editorial refers
The results of recent randomized clinical trials performed in patients with acute ST elevation myocardial infarction suggest that the short-term mortality of these patients is around 56% or even less. That would imply that there is little room for improvement in our efforts to reduce mortality in patients with acute myocardial infarction. Unfortunately, this is not the case in the real world situation in Europe and there are still many things to improve. This insight comes from well designed prospective national and international registries performed in patients with acute coronary syndromes.
A large number of randomized studies with several thousands of patients
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Epidemiology of acute myocardial infarction in the Italian CCU network: The BLITZ Study
- Antonio Di Chiara, Francesco Chiarella, Stefano Savonitto, Donata Lucci, Leonardo Bolognese, Stefano De Servi, Cesare Greco, Alessandro Boccanelli, Pietro Zonzin, Stefano Coccolini, Aldo P. Maggioni, and on behalf of the BLITZ Investigators
EHJ 2003 24: 1616-1629.[Abstract] [Full Text]